@article{ATM27288,
author = {Ming Li and Cheng Zhan},
title = {Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 6},
year = {2019},
keywords = {},
abstract = {Different from general radiotherapy, stereotactic ablative radiation (SABR), also referred to as stereotactic body radiotherapy (SBRT), delivers very high radiation doses to restricted volumes using multiple, precisely-aimed radiotherapy beams, which has a better effect on survival and tumor control, and has gained substantial attention in recent years (1,2).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/27288}
}